Low Testosterone Associated with Increased Dementia Risk

Share this article:

Low levels of total and bioavailable testosterone may be associated with an increased risk of dementia in elderly men, according to French investigators.

From a cohort of 3,650 men aged 65 years and older, Laure Carcaillon, MD, of Inserm in Villejuif, France, and collaborators compared 105 men with incident dementia and a random sample of 413 men without dementia. The median follow-up period was 3.1 years. Compared with the middle tertile of total testosterone (total-T) level, the lower and upper tertiles were associated with a 2.3 times and 1.9 times increased risk of dementia, respectively. Low bioavailable testosterone (bio-T) also was associated with a greater risk for dementia, especially among men aged 80 years and older, investigators reported online ahead of print in Alzheimer's & Dementia. In men aged 80 and older, low bio-T was associated with a significant threefold increased risk of dementia; in men younger than 80, it was associated with a nonsignificant 7% increased risk.

Additionally, the risk of dementia associated with low bio-T was greater in men with a high level of education compared with men who had a low level of education.

Taken together, the authors noted, their results support the hypothesis of a deleterious effect of low testosterone concentrations on brain aging, and also suggest that high levels of total-T could increase this risk.

Share this article:
You must be a registered member of RUN to post a comment.
close

Next Article in Hypogonadism

More in Hypogonadism

Hypogonadism May Raise Death Risk in Men with CKD

Hypogonadism May Raise Death Risk in Men with ...

Patients in the second lowest quintile of testosterone level had a 53% increased death risk compared with those in the highest quintile.

High Estradiol Boosts Libido in Men on Testosterone Therapy

High Estradiol Boosts Libido in Men on Testosterone ...

Elevated serum estradiol is associated with increased libido in men receiving TST.

FDA to Review Testosterone Therapy Safety

FDA to Review Testosterone Therapy Safety

Agency pointed to recent studies citing possible heightened heart risk tied to the treatments.